Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
10.4 SEK
2.41 B SEK
22.12 B SEK
172.71 M
About SWEDISH ORPHAN BIOVITRUM AB
Sector
CEO
Guido Oelkers
Headquarters
Solna
Website
Founded
2001
ISIN
SE0000872095
FIGI
BBG007R9HLM6
Swedish Orphan Biovitrum AB engages in the research, development, manufacture, and sale of pharmaceuticals. It operates through the Haematology, Immunology, and Specialty Care segments. The Haemotology segment focuses on haemophilia medicines Elocta and Alprolix. The immunology segment offers treatment for serious, disabling, and life-threatening diseases. The Specialty Care segment specializes in the treatment of genetic and metabolic diseases. The company was founded in 2001 and is headquartered in Solna, Sweden.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 0MTD is 312.4 SEK — it hasn't changed in the past 24 hours. Watch SWEDISH ORPHAN BIOVITRUM AB NPV stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on LSIN exchange SWEDISH ORPHAN BIOVITRUM AB NPV stocks are traded under the ticker 0MTD.
0MTD stock has fallen by −0.32% compared to the previous week, the month change is a 7.13% rise, over the last year SWEDISH ORPHAN BIOVITRUM AB NPV has showed a 19.42% increase.
We've gathered analysts' opinions on SWEDISH ORPHAN BIOVITRUM AB NPV future price: according to them, 0MTD price has a max estimate of 400.00 SEK and a min estimate of 275.00 SEK. Watch 0MTD chart and read a more detailed SWEDISH ORPHAN BIOVITRUM AB NPV stock forecast: see what analysts think of SWEDISH ORPHAN BIOVITRUM AB NPV and suggest that you do with its stocks.
0MTD reached its all-time high on Oct 28, 2024 with the price of 354.6 SEK, and its all-time low was 1.6 SEK and was reached on Aug 12, 2021. View more price dynamics on 0MTD chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
0MTD stock is 0.00% volatile and has beta coefficient of 1.22. Track SWEDISH ORPHAN BIOVITRUM AB NPV stock price on the chart and check out the list of the most volatile stocks — is SWEDISH ORPHAN BIOVITRUM AB NPV there?
Today SWEDISH ORPHAN BIOVITRUM AB NPV has the market capitalization of 106.74 B, it has increased by 0.06% over the last week.
Yes, you can track SWEDISH ORPHAN BIOVITRUM AB NPV financials in yearly and quarterly reports right on TradingView.
SWEDISH ORPHAN BIOVITRUM AB NPV is going to release the next earnings report on Feb 5, 2025. Keep track of upcoming events with our Earnings Calendar.
0MTD earnings for the last quarter are 4.27 SEK per share, whereas the estimation was 2.21 SEK resulting in a 93.36% surprise. The estimated earnings for the next quarter are 2.88 SEK per share. See more details about SWEDISH ORPHAN BIOVITRUM AB NPV earnings.
SWEDISH ORPHAN BIOVITRUM AB NPV revenue for the last quarter amounts to 6.89 B SEK, despite the estimated figure of 6.03 B SEK. In the next quarter, revenue is expected to reach 6.85 B SEK.
0MTD net income for the last quarter is 1.46 B SEK, while the quarter before that showed 224.00 M SEK of net income which accounts for 553.57% change. Track more SWEDISH ORPHAN BIOVITRUM AB NPV financial stats to get the full picture.
No, 0MTD doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 25, 2024, the company has 1.77 K employees. See our rating of the largest employees — is SWEDISH ORPHAN BIOVITRUM AB NPV on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. SWEDISH ORPHAN BIOVITRUM AB NPV EBITDA is 9.53 B SEK, and current EBITDA margin is 35.37%. See more stats in SWEDISH ORPHAN BIOVITRUM AB NPV financial statements.
Like other stocks, 0MTD shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade SWEDISH ORPHAN BIOVITRUM AB NPV stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So SWEDISH ORPHAN BIOVITRUM AB NPV technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating SWEDISH ORPHAN BIOVITRUM AB NPV stock shows the buy signal. See more of SWEDISH ORPHAN BIOVITRUM AB NPV technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.